At Morgan Stanley's 14th Annual Laguna Conference, EMCOR Group's CEO Anthony Guzzi explained that the company specializes in installing, repairing, and maintaining mechanical and electrical systems across various sectors including healthcare, commercial, and transportation. EMCOR is notably one of the largest specialty trade contractors serving the data center market, operating in nearly every major data center location. This diverse portfolio positions EMCOR as a key player in infrastructure services, with potential growth tied to expanding data center demand.
EMCOR Group, Inc. is the subject of this story, and here is Pluang's Industrials sector market data as of Sep 17, 2026 21:51 WIB: Among 76 priced US Industrials stocks, 42 rose and 34 fell today. LYFT Inc traded at USD 15.27 with a 1-day change of -2.68%, while Star Bulk Carriers Corp rose 2.67% to USD 31.70, and EHang Holdings Ltd increased 2.64% to USD 4.66.
Disc Medicine's stock surged 38% following positive Phase 3 trial results for its drug bitopertin, which showed efficacy and safety in treating erythropoietic protoporphyria. BMO Capital raised its price target from $100 to $120 and maintained an Out...
Qualcomm executive Ann C. Chaplin sold 1,827 shares of the company's stock for $319,268.25 under a Rule 10b5-1 trading plan, reducing her holdings by 6.62%. Qualcomm's stock price recently traded below its 50-day and 200-day moving averages, signalin...
BOK Financial is set to announce its Q3 2026 earnings after market close on October 19, with analysts forecasting earnings per share between $2.52 and $2.54 and revenue near $571 million. The company has a strong history of surpassing earnings estima...
AIBotics has completed the acquisition of NovaCore Labs' assets from PlayJamaica Limited, gaining technology, software, drones, mapping equipment, and customer contracts. This move expands AIBotics' platform in Jamaica and the Caribbean, enhancing AI...
EyePoint's stock dropped sharply after its DURAVYU treatment did not meet the primary endpoint in a Phase 3 trial for wet age-related macular degeneration (wet AMD). Although DURAVYU showed some vision improvement and reduced the need for additional ...
